Pursuant to Regulation 57 (4) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, Ind-Swift Laboratories has informed about details of interest obligations in respect of the Non-Convertible Debentures of the Company, which are due to be paid during the quarter ending 30th September, 2023-Q2 F/Y 2023-24.
The above information is a part of company’s filings submitted to BSE.